Safety and efficacy of cisplatin and nab-paclitaxel pressurised intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal carcinomatosis: Nab-PIPAC phase 1b study.

Undurraga M, Lang N, Koessler T, Diciolla A, Di Marco M, Mach N, Raimond C, Genoud V, Du Bois V, Tille JC, Bornand A, Moore JS, Weiner M, Smekens L, Sandoval JL, Terzic J, Christinat Y, Veillard J, Tsantoulis P, Thoueille P, Mercier T, Monig S, Petignat P, Toso C, Decosterd L, Hübner M, Labidi-Galy I, Ris F

Open source

DOI
10.1016/j.ebiom.2026.106477
Published
2026 Sep 11
Container
EBioMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2026.106477,
  title = {Safety and efficacy of cisplatin and nab-paclitaxel pressurised intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal carcinomatosis: Nab-PIPAC phase 1b study.},
  author = {Undurraga M and Lang N and Koessler T and Diciolla A and Di Marco M and Mach N and Raimond C and Genoud V and Du Bois V and Tille JC and Bornand A and Moore JS and Weiner M and Smekens L and Sandoval JL and Terzic J and Christinat Y and Veillard J and Tsantoulis P and Thoueille P and Mercier T and Monig S and Petignat P and Toso C and Decosterd L and Hübner M and Labidi-Galy I and Ris F},
  year = {2026},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2026.106477},
  url = {https://doi.org/10.1016/j.ebiom.2026.106477}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of cisplatin and nab-paclitaxel pressurised intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal carcinomatosis: Nab-PIPAC phase 1b study.
AU  - Undurraga M
AU  - Lang N
AU  - Koessler T
AU  - Diciolla A
AU  - Di Marco M
AU  - Mach N
AU  - Raimond C
AU  - Genoud V
AU  - Du Bois V
AU  - Tille JC
AU  - Bornand A
AU  - Moore JS
AU  - Weiner M
AU  - Smekens L
AU  - Sandoval JL
AU  - Terzic J
AU  - Christinat Y
AU  - Veillard J
AU  - Tsantoulis P
AU  - Thoueille P
AU  - Mercier T
AU  - Monig S
AU  - Petignat P
AU  - Toso C
AU  - Decosterd L
AU  - Hübner M
AU  - Labidi-Galy I
AU  - Ris F
PY  - 2026
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2026.106477
UR  - https://doi.org/10.1016/j.ebiom.2026.106477
ER  - 

APA

M, U., N, L., T, K., A, D., M, D. M., N, M., C, R., V, G., V, D. B., JC, T., A, B., JS, M., M, W., L, S., JL, S., J, T., Y, C., J, V., P, T., P, T., T, M., S, M., P, P., C, T., L, D., M, H., I, L., & F, R. (2026). Safety and efficacy of cisplatin and nab-paclitaxel pressurised intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal carcinomatosis: Nab-PIPAC phase 1b study.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2026.106477

Source records